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Inflammatory mediators such as endotoxin, interleukin-l,6 (IL- lp) and tumor necrosis factor~ (TNF-=) dose-dependently inc r~ the expression 
of tissue factor on the surface of cultured bovine aortic endothelial ¢¢11s (ABAE), human umbilical vein endothelial cells (HUVEC) and human 
monocytes. In ABAE, ¢ndotoxin-, IL-Ip- and TNFa-induced tissue factor expression was suppressed by interleukin-4 (IL-4) which also neutralized 
the pyrogeni¢ effect of ¢ndotoxin in HUVEC and moaocytes. IL-4 did not alter TN F-a-induced proeoagulant changes in HUVEC and monocytes 
but strongly protected the monoeyte surface against IL-I/~-induced proeoagulant changes. 
1, INTRODUCTION 
Tissue factor (TF) is an ubiquitous membrane-an- 
chored glycoprotein that initiates blood coagulation by 
forming a complex with circulating factors VI I and Vlla 
[1]. Under normal circumstances, endothelial cells do 
not express TF activity while they constitutively express 
thrombomodulin (TM) which accelerates the thrombin- 
catalysed activation of protein C thus contributing to 
the anticoagulant properties of the endothelium. In 
some pathological situations, when the endothelium or 
the monocytes are exposed to inflammatory mediators, 
they can acquire procoagulant properties [2--4]. Indeed, 
stimulation of these cells by inflammatory compounds 
such as ¢ndotoxin, interleukin-l,6 (IL-I,6) or tumor ne- 
crosis faetor-~ (TNF-~) may alter the anti-thrombotic 
properties of the endothelium by inducing the expres- 
sion of TF and the down-regulation of TM, therefore 
promoting coagulation and thrombosis [2-4]. Only a 
few compounds have been shown to reduce the effect of 
these inflammatory mediators [5] and IL-4 has been 
recently described as an inhibitor of pyrogen-induced 
down-regulation of TM in cultured human vascular en- 
dothelial ceils [6]. 
We investigated the effect of IL-4 on the expression 
of TF induced by various inflammatory mediators on 
the surface of endothelial cells and monocytes. 
2. MATERIALS AND METHODS 
2.1. Cells 
Adult bovine aortic endothelial cells (ABAE) (passage 7-10) were 
isolated and cultured as already d~cribed [7] in 96-well microplates 
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in Dulbeeco's modified Eagle medium, supplemented with 10% fetal 
calf serum and bovine basic fibroblast growth factor (1 ng/mi) (Amcr- 
sham, France). 
Human ambilical vein endothelial cells (HUVEC) (passage 3-10) 
were isolated and cultured as described [8] in 96-well mlcroplates in
F l ~-I lure'S medium supplemented with 10% fetal calf serum, endothe- 
lial cell growth factor (30/~g/ml) and heparin (100/tg/ml) (Sigma, 
France). 
Mononuclear cells were obtained from human heparinized blood as 
described by Boyum [9]. Cells were plated for 30 rain at 370C into 
96-well microplates (10 s calls/well). Non-adherent ¢¢11s were then har- 
vested and adherent monoeyte (5 x 10 ~ cells/well) were used for the 
assay. 
2.2. Determination of tLssue factor activity on the cells 
Procoagulant activity was assayed according to $uprenant ¢tal. 
[10l. Briefly, adherent cells were incubated at 37"C in M-199 (without 
Phenol red) with ¢ndotoxin (LPS-lipopolysaccharide from E. coti 
strain: 055:B5) (Sigma, France), IL-I/~ or TNF~ (Teba, France) in the 
absence or presen~ of the indicated concentrations of IL-4 (Tebu, 
France). Incubation lasted for 18 h for ABAE and monoeytes and 6 
h for HUVEC. The mediam was removed and wells were washed twice 
with 1 ml of phosphate-bulTered saline (PBS) and incubated for 45 rain 
at 37"C with 250 pl of M-199 containlng PPSB (0.44 U/ml FVII) 
(lntertran~fusion, France) and 100/t~/ml of substrate $2222 (Kabi, 
Sweden). The optical density (OD) was measured at 405 nm. The TF 
activity was obtained from a standard curve (log [~OD~o~/min] vs. log 
[U/roll) using serial dilations of rabbit brain thromboplastin in M-199 
assayed as described above. Undiluted thromboplastin was arbitrarily 
assigned a value of I U/ml. The TF activity was normalized to the cell 
counts from the same well and expressed as,aU of TF/10 s ¢¢11s. 
3. RESULTS AND DISCUSSION 
3.1. Effect of LPS, IL-I~ and TNF-~ on TF expression 
in ABAE, HUVEC and monocytes 
The addition of LPS, IL-I/~ or TNF-0t to adherent 
cells resulted in a time-dependent expression of TF on 
the cell surface (Fig. 1). For both ABAE and mon- 
ocytes, increased TF activity was observed as early as 
4 h and reached a maximum 18 h after stimulation, in 
HI.TVEC, LPS, IL-Ip or TNF-= induced rapid surface 
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Fig. l. Time course of LPS, 1L-ifl or TNF-~-stimulatcd TF expression i  endothelial cells and monocytes. ABAE (A), HLTVEC (B) and human 
monocytes (C) were incubated with the indicated concentrations of LPS (e), 1L-lfl (I), TNF-~ (A) or the vehicl¢ (o). Results are expressed as 
mean -2_ S.D. (n = 6). 
expression of TF which reached a maximum around 6 
h. These results confirm previous observations showing 
that these compounds induce ndothelial cell procoagu- 
lant activity while suppressing cell-surface anticoagu- 
lant activity [11,12]. For both ABAE and monocytes, 
TF expression i control wells did not vary significantly 
over the 24-h incubation period and the passage number 
had no effect on the procoagulant activity of the various 
inflammatory mediators (not shown). 
Exposure of confluent ABAE or HUVEC and adher- 
ent monocytes to increasing concentrations of LPS, IL- 
lfl or TNF-;¢ resulted in a significant increase in TF 
expression on the cell surface (Fig. 2). LPS-stimulated 
expression of TF occurred in a dose-dependent manner, 
a maximal response being attained for the three cell 
types around 1 ng/ml. After incubation with the highest 
doses of LPS, human monocytes exhibited higher max- 
imal levels of TF, compared to LPS-stimulated ABAE 
or HUVEC. Indeed, a -30-fold difference was observed 
between endothelial cells and monocytes. Such a differ- 
ence between cell types was also observed after stimula- 
tion with IL-1/~, monocytes being of a higher sensitivity 
than endothelial cells for IL-l/J-mediated TF expression 
(Fig. 2C). In both endothelial cell types, TNF-= stimu- 
lated TF expression in a dose-dependent manner with 
a maximum effect around 10 ng/ml. In monocytes how- 
ever, TFN~t-induced TF expression was lower than that 
observed for LPS or IL-lfl in these cells (Fig. 2C). 
3.2. Effect of lL.4 on pyrogen-induced TF expression in 
ABAE, HUVEC and monocytes 
As shown in Fig. 3A, IL-4 counteracted in a dose- 
dependent manner IL-l]J-, TNFa- and LPS-induced TF 
induction in ABAE. However, IL-4 was not able to 
totally abolish pyrogen-induced TF expression, the 
maximum effect (about 60% inhibition) being attained 
around the dose of 1 ng/ml. The ICso value (concentra- 
tion which inhibited 50% of the pyrogen-induced TF
expression) with regard to the effect of all inflammatory 
mediators was between 0.05 and 0.5 ng/ml. 
In HUVEC, IL-4 strongly reduced LPS-induced TF 
expression with an ICs0 value of 0.5 ng/ml. With regard 
to [L-Ip or TNF-0¢, however, IL-4 did not show any 
inhib!tory effect. This observation confirms the results 
published recently by Kapiotis et al. [6] showing no 
influence of IL-4 on pyrogen-induced TF expression i
HUVEC but they raise a controversy with regard to the 
effect of LPS. One possible xplanation for such a dis- 
crepancy may be the great difference in the amount of 
LPS used in both studies. Indeed, the 4000-fold lower 
LPS concentration used for optimal TF expression i  
our experimental conditions, may give higher sensitivity 
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Fig. 2. Effect of LPS, IL-lfl and TNF.~ on TF expression i  ABAE, HUVEC and monocytes. ABAE (A), HUVEC (B) and human monocytes 
(C) were incubated with increasing concentrations of LPS (e), IL-1]J (B) or TNF.cz (A). Results are expressed as mean _+ S.D. (n = 6). 
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Fig. 3. Effect of IL-4 on LPS, 1L-1,8 or TNFg-lnduced TF expression i ABAE, HUVEC and monocytes. Increasing concentrations of IL-4 were 
incubated with ABAE (A), HUVEC (B) or human monocytes (C) in the presence of PBS (o), LP$ (e), IL-I/~ (=) or TNF.a (a) at the indicated 
concentrations. Results are expressed as % inhibition of the control response (n = 6). 
and therefore nable easier detection of an inhibitory 
effect of IL-4. 
In human monocytes, IL-4 strongly reduced IL-1/~- 
induced TF expression with an iCs0 value of 0.4 ng/ml 
(Fig. 3C). With regard to the pyrogenic effect of TNF-oc, 
IL-4 remained ineffective whereas it slightly inhibited 
the procoagulant effect of LPS with an ICso value of 10 
ng/ml. 
Although pyrogen-induced pro-hemostatie changes 
in the endothelial cell surface have been known for sev- 
eral years, a substance that effectively counteracts hese 
effects has so far not been described. Recently, IL-4, a 
product of activated T-cells, was shown to exert anti- 
inflammatory effects on human endothelial cells and 
monocytes [13-15] and to neutralize the pyrogen-in- 
dueed own-regulation f thrombomodulin activity [6]. 
Our results together with the findings of others [6,13- 
15] provide evidence which shows that IL-4 effectively 
counteracts the procoagulant process resulting from the 
interaction of inflammatory mediators with endothelial 
cells and monocytes. 
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